Environmental Pollution from Pharmaceuticals
- PMID: 41010283
- PMCID: PMC12471260
- DOI: 10.3390/life15091341
Environmental Pollution from Pharmaceuticals
Abstract
Pharmaceuticals are invaluable allies in human and veterinary medicine, but their indiscriminate use can transform them into formidable pollutants-a threat that remains largely underestimated. The growth of the pharmaceutical market has increased the environmental presence of drugs, both as original compounds during production and as metabolites following administration. Particularly concerning is the presence of antibiotics in wastewater, which contributes to the development and spread of bacterial resistance. This review analyzes the primary causes of environmental pharmaceutical pollution and its impact on ecosystems. We describe the most significant results obtained from analyzing wastewater, primarily in Italy, but also in other European countries, and examine the official positions of environmental protection organizations.
Keywords: drugs; environment; pollution.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Mezzelani M., Gorbi S., Fattorini D., D’eRrico G., Consolandi G., Milan M., Bargelloni L., Regoli F. Long-term exposure of Mytilus galloprovincialis to diclofenac, ibuprofen and ketoprofen: Insights into bioavailability, biomarkers and transcriptomic changes. Chemosphere. 2018;198:238–248. doi: 10.1016/j.chemosphere.2018.01.148. - DOI - PubMed
-
- European Commission . Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee: European Union Strategic Approach to Pharmaceuticals in the Environment. European Commission; Brussels, Belgium: 2019.
-
- Mudgal S., De Toni A., Lockwood S., Salès K., Backhaus T., Sorensen B.H. Study on the Environmental Risks of Medical Products, Final Report. Executive Agency for Health and Consumers; Luxembourg: 2013.
Publication types
LinkOut - more resources
Full Text Sources